Ignite Creation Date:
2024-05-06 @ 3:51 PM
Last Modification Date:
2024-10-26 @ 1:58 PM
Study NCT ID:
NCT04786730
Status:
COMPLETED
Last Update Posted:
2023-07-13
First Post:
2021-02-25
Brief Title:
A Trial to Assess the Pharmacokinetics Safety and Tolerability of Centanafadine Capsules in Pediatric Subjects With Attention-deficit Hyperactivity Disorder
Sponsor:
Otsuka Pharmaceutical Development Commercialization Inc
Organization:
Otsuka Pharmaceutical Development Commercialization Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-09
Start Date Type:
ACTUAL
Primary Completion Date:
2023-04-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-04-26
Completion Date Type:
ACTUAL
First Submit Date:
2021-02-25
First Submit QC Date:
March 3 2021
Study First Post Date:
2021-03-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-07-11
Last Update Post Date:
2023-07-13
Last Update Post Date Type:
ACTUAL